Boston, MA. April 05, 2017 – Metrics Champion Consortium (MCC)—a trusted partner in the clinical trials industry—announced today a newly published MCC Industry Practices Insight Report, “Clinical Trial Site Data Entry Study: An examination of how organizations measure site data entry cycle times, performance expectations compared to actual results and site management strategies” revealing that organizations consider this to be a very important metric. The report features twenty exhibits highlighting the following key findings:
- Organizations encourage timely data entry to identify safety signals early and increase data quality.
- Industry lacks agreement on how to define the “data entry complete” time point – data entry “complete” when a single data point for the visit has been entered into EDC and data entry “complete” when all data for a complete visit have been entered into EDC are most prevalent responses
- Site data entry cycle time expectations for “single data” time point group not significantly different from “all data” entered group
- Some organizations cite challenges with measuring data entry cycle time related to EDC system constraints.
“With the adoption of the ICH E6 (R2) Addendum and the increasing focus on risk management in clinical trials, timely data entry by sites following subject visits is becoming more important,” said Linda Sullivan, co-founder and president at the industry group Metrics Champion Consortium, author of the new report. “Delayed data entry can lead to increased risk both to subjects and the trial. This study shines light on a real industry gap that could itself be a significant source of risk unless urgently addressed. It’s time for the industry to come together across the value chain to resolve the definition, use, expectations and continuous improvement of this important cycle time metric.”
MCC conducted the 28 question, web-based survey between June – August 2016. There were 35 respondents primarily from sponsors and Contract Research Organizations (CROs) both large and small. For more information on purchasing the MCC Industry Practices Insight Report, “Clinical Trial Site Data Entry Study: An examination of how organizations measure site data entry cycle times, performance expectations compared to actual results and site management strategies”, please email email@example.com or visit http://metricschampion.org/sitedataentrystudy/
About Metrics Champion Consortium (MCC)
MCC—a trusted partner in the clinical trials industry—identifies what to measure, how to assess the crucial components of what is changing and how the industry is responding to address these changes to make improvements. MCC continually brings you new insights into the leading trends within the industry. For more information about MCC metric sets and tools, metric education programs and how you can participate in MCC work groups, please visit http://www.metricschampion.org